Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Current Deferred Revenue (2017 - 2024)

Cavitation Technologies (CVAT) has disclosed Current Deferred Revenue for 11 consecutive years, with $382000.0 as the latest value for Q1 2024.

  • Quarterly Current Deferred Revenue fell 13.77% to $382000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $382000.0 through Mar 2024, down 13.77% year-over-year, with the annual reading at $391000.0 for FY2023, 388.75% up from the prior year.
  • Current Deferred Revenue hit $382000.0 in Q1 2024 for Cavitation Technologies, down from $555000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.0 million in Q1 2022 to a low of $36000.0 in Q3 2022.
  • Historically, Current Deferred Revenue has averaged $521812.5 across 5 years, with a median of $474500.0 in 2020.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 96.25% in 2022 and later soared 1830.56% in 2023.
  • Year by year, Current Deferred Revenue stood at $506000.0 in 2020, then skyrocketed by 89.53% to $959000.0 in 2021, then crashed by 73.2% to $257000.0 in 2022, then surged by 115.95% to $555000.0 in 2023, then tumbled by 31.17% to $382000.0 in 2024.
  • Business Quant data shows Current Deferred Revenue for CVAT at $382000.0 in Q1 2024, $555000.0 in Q4 2023, and $695000.0 in Q3 2023.